Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.53 USD | +2.54% | +5.22% | -45.95% |
May. 08 | Baird Adjusts Price Target on EyePoint Pharmaceuticals to $38 From $46, Keeps Outperform Rating | MT |
May. 08 | Earnings Flash (EYPT) EYEPOINT PHARMACEUTICALS Posts Q1 Revenue $11.7M | MT |
Financials (USD)
Sales 2024 * | 41.17M | Sales 2025 * | 12.14M | Capitalization | 636M |
---|---|---|---|---|---|
Net income 2024 * | -127M | Net income 2025 * | -188M | EV / Sales 2024 * | 10.2 x |
Net cash position 2024 * | 215M | Net cash position 2025 * | 348M | EV / Sales 2025 * | 23.7 x |
P/E ratio 2024 * |
-4.94
x | P/E ratio 2025 * |
-3.58
x | Employees | 121 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.46% |
Latest transcript on EyePoint Pharmaceuticals, Inc.
1 day | +1.08% | ||
1 week | +9.11% | ||
Current month | -30.57% | ||
1 month | -45.57% | ||
3 months | -58.76% | ||
6 months | +90.94% | ||
Current year | -47.12% |
Managers | Title | Age | Since |
---|---|---|---|
Jay Duker
CEO | Chief Executive Officer | 66 | 16-09-26 |
George Elston
DFI | Director of Finance/CFO | 59 | 19-11-13 |
Said Saim
CTO | Chief Tech/Sci/R&D Officer | 66 | 19-06-09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jay Duker
CEO | Chief Executive Officer | 66 | 16-09-26 |
Wendy DiCicco
BRD | Director/Board Member | 56 | 19-07-14 |
David Guyer
BRD | Director/Board Member | 64 | 19-01-24 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.84% | 11 M€ | -6.03% | - | |
0.37% | 4 M€ | -5.15% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-14 | 12.57 | +2.86% | 127 400 |
24-05-13 | 12.22 | +1.08% | 1,182,013 |
24-05-10 | 12.09 | -4.58% | 1,070,375 |
24-05-09 | 12.67 | +9.60% | 2,110,475 |
24-05-08 | 11.56 | -2.61% | 1,435,111 |
Delayed Quote Nasdaq, May 13, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-47.12% | 636M | |
+29.98% | 682B | |
+30.34% | 586B | |
-3.52% | 364B | |
+18.59% | 327B | |
+4.07% | 285B | |
+16.21% | 240B | |
+9.66% | 209B | |
-6.83% | 203B | |
+7.09% | 165B |
- Stock Market
- Equities
- EYPT Stock